
Medpace Holdings (MEDP) Stock Forecast & Price Target
Medpace Holdings (MEDP) Analyst Ratings
Bulls say
Medpace Holdings is forecasting an increase in passthrough revenues by 200-300 basis points in the second half of the year compared to the elevated levels in the second quarter, indicating strong business momentum. The company experienced a robust first quarter, leading to higher Request for Proposal (RFP) volumes and contributing to positive growth indicators. Additionally, Medpace anticipates a return to a book-to-bill ratio exceeding 1.15x in the third quarter, reflecting strong demand for its services and a healthy revenue outlook.
Bears say
The analysis of Medpace Holdings indicates a concerning trend regarding its backlog cancellations, which have fluctuated significantly and were at the higher end of normal levels for the quarter. While the company anticipates no significant decline in Direct Service revenue for 2026, there remains a significant degree of uncertainty regarding its growth potential. Furthermore, the adjusted EBITDA estimates for 2025 and 2026 reflect an increase but are influenced by ongoing hiring costs, alongside a projected decrease in passthrough revenues, contributing to a negative outlook on the company's financial performance.
This aggregate rating is based on analysts' research of Medpace Holdings and is not a guaranteed prediction by Public.com or investment advice.
Medpace Holdings (MEDP) Analyst Forecast & Price Prediction
Start investing in Medpace Holdings (MEDP)
Order type
Buy in
Order amount
Est. shares
0 shares